Optimizing treatment and preventing kidney stone recurrence through interdisciplinary care
Study on Treatment Optimization and Nephrolithiasis Recurrence Prevention With Interdisciplinary Care
This study is trying to see if different lifestyle and diet changes can help people with kidney stones prevent them from coming back.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 164 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Brugmann University Hospital Academic / other |
| Locations | 1 site (Brussels) |
| Trial ID | NCT06367894 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients with kidney stone disease at CHU Brugmann Hospital in Brussels. It aims to assess the effectiveness of various preventive measures in a real-world clinical setting, considering factors such as metabolism, diet, and lifestyle. By conducting a complete metabolic assessment, the study seeks to identify and correct the underlying causes of urinary stone formation. The goal is to gather data on the combined effects of different interventions to improve patient outcomes.
Who should consider this trial
Good fit: Ideal candidates are patients with a current or past history of kidney stones who have been treated at CHU Brugmann Hospital.
Not a fit: Patients without a history of kidney stones or those who do not meet the inclusion criteria will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more effective prevention strategies for kidney stone recurrence, improving patients' quality of life.
How similar studies have performed: While there is limited data on the combined effectiveness of preventive measures in routine practice, previous studies have documented individual interventions' effectiveness.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients of the CHU Brugmann Hospital who fulfill the criteria of active or past history of kidney stone, from 01/01/2018 till 31/10/2023 * Minimum follow-up time of 2 months with biochemical and clinical results available Exclusion Criteria: - None
Where this trial is running
Brussels
- CHU Brugmann — Brussels, Belgium (Recruiting)
Study contacts
- Study coordinator: Sirika Chhem
- Email: Sirika.Chhem@ulb.be
- Phone: 024772641
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.